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Wei Li1,2, Ze-hua Chen4, Zhi-Min Wang3,5, Da-zhi Wang3, Kai-Yue Zhang3 and Jian-Jun Liu1,2,6
Psoriasis linkage to 4q28–32 (PSORS9) was initially identified by our genome-wide scan in 61 Chinese families
and subsequently supported by a meta-analysis of five genome-wide linkage scans of European populations. In
this study, we performed a follow-up analysis of PSORS9 using an additional 90 families and improved marker
coverage. Joint analysis of all 151 families obtained significant linkage evidence (HLOD¼ 4.53, nonparametric
linkage (NPL)¼ 4.03 (P¼ 0.000003)) at the marker interval D4S2997–D4S3033, and the same was obtained for the
analysis of the independent new families (HLOD¼ 4.33, NPL¼ 3.15 (P¼ 0.00004)). The linkage evidences from the
whole families and the new families exceeded the genome-wide criteria for significant linkage. Furthermore, by
performing an ordered subset analysis using mean age at onset as a covariate, we demonstrated that evidence
for linkage to PSORS9 is concentrated in the early-onset families and suggested that further study of PSORS9
should focus on early-onset patients. This finding is contradictory to what was found in the Icelandic
population and, together with other linkage results, suggests that Chinese and European populations are
genetically different for linkage to PSORS9, which may partially explain the influence of ethnic factors on the
varying prevalence of psoriasis.
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INTRODUCTION
Psoriasis (OMIM*177900) is a common, immunologically
mediated and hyperproliferative skin disease characterized by
strong familial aggregation (Elder et al., 1994), which has a
worldwide distribution with prevalence varying according to
race and geographical location (Christophers, 2001). The
estimated prevalence of psoriasis is 2–5% in the Caucasian
population (Nevitt and Hutchinson, 1996) and 0.1–0.3% in the
Far East (Simons, 1949; Yui, 1984). In China, psoriasis affects
0.123% of the population and there have been more than 3
million cases reported since 1984 (Shao, 1996). The influence
of ethnic factors is particularly evident when one compares
prevalence rates within the United States where the prevalence
in the black population is far lower than that in the remainder
of the population (Kennney, 1971; Schon and Boehncke,
2005). Such ethnic factors are still poorly understood, and
genetic difference between ethnic populations could play a
role, as psoriasis is a genetically heterogeneous disease.
PSORS9 locus at 4q28–32 was initially suggested by our
genome-wide scan in 61 Chinese Han families with psoriasis
(Zhang et al., 2002). Before our study, eight genome-wide
linkage scan studies had been performed in psoriatic families
of European populations (Tomfohrde et al., 1994; Matthews
et al., 1996; Nair et al., 1997; Trembath et al., 1997;
Capon et al., 1999; Samuelsson et al., 1999; Lee et al., 2000;
Veal et al., 2001), but linkage evidence at the PSORS9 locus
was never strong enough to be reported. Intriguingly, a
subsequent meta-analysis of the linkage results from five of
these genome-wide linkage scans provided strong supporting
evidence for PSORS9 (Sagoo et al., 2004). More recently, by
stratifying their psoriatic families of the Icelandic population
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according to age at onset (AAO), Karason et al. (2005)
reported an LOD score of 3.6 at PSORS9 locus in the
psoriatic families of late-onset, but the analysis of their whole
family sample yielded very moderate evidence (LOD less
than 1.5). Their results provided further evidence for AAO
to be a surrogate marker of genetic heterogeneity in psoriasis,
as suggested in previous studies (Raychaudhuri and Gross,
2000; Ferrandiz et al., 2002; Stuart et al., 2002).
In this study, we performed a follow-up study of the
PSORS9 locus using an expanded sample of 151 Chinese
psoriatic families. Our linkage analysis of all 151 families as
well as the independent sample of the 90 families provided
confirmative evidence for linkage and refined the PSORS9
locus to a small region at 4q31–32. Furthermore, we
performed an ordered subset analysis (OSA) using AAO as
a covariate and clearly demonstrated that evidence for
linkage to PSORS9 locus is concentrated in the families of
early-onset psoriasis in the Chinese population.
RESULTS
Linkage analysis in 151 families
To improve marker coverage, seven additional microsatellite
markers were selected within the region (between D4S1575
and D4S2979) surrounding the original linkage peak of our
genome-wide scan at the PSORS9 locus (Zhang et al., 2002).
Together with six markers used in our genome-wide scan
analysis within this region, 13 microsatellite markers
(D4S1575, D4S2972, D4S2939, D4S420, D4S424, D4S2981,
D4S3008, D4S413, D4S2997, D4S3033, D4S3046, D4S620,
and D4S2979) were analyzed in this study providing dense
marker coverage of about 3 cM per marker around the
PSORS9 locus. The map positions of the 13 markers were
determined according to the genetic map at the Marshfield
(http://www.marshmed.org/genetics). Multipoint marker in-
formation content within the region, as evaluated by using
the Hidden Markov Model implemented in GENEHUNTER
(Rijsdijk and Sham, 2002), was improved from 76.5 to 93.1%
by adding the seven new markers.
We first performed a joint linkage analysis of the 61
original and 90 new families. Multipoint parametric analysis
yielded a highly significant heterogeneity LOD (HLOD) score
of 4.53 (a¼45%) at the marker interval D4S2997–D4S3033,
which was supported by a highly significant nonparametric
linkage (NPL) score of 4.03 (P¼0.000003) at the same
marker interval (Figure 1 and Table 1). Both the multipoint
HLOD and NPL scores exceeded the genome-wide criteria
for significant linkage evidence (Lander and Kruglyak, 1995).
Two-point linkage analysis also provided supportive
evidence, although LOD scores were less significant. The
highest two-point HLOD score was 3.59 obtained at marker
D4S413, and supportive LOD scores were also obtained
at four surrounding markers (out of 13 markers): 1.95 at
D4S2981, 3.14 at D4S3008, 3.11 at D4S2997, and 1.32
at D4S3033.
We then performed the linkage analysis by using the 61
original and 90 new families separately. The overall patterns
of linkage evidence from the 61 original and 90 new families
were very similar to that from all 151 families (Figure 1). The
analysis of the 61 original families yielded a multipoint NPL
score of 2.65 (P¼ 0.004) and HLOD score of 1.12 at the
marker interval D4S2997–D4S3033 (Figure 1). These LOD
scores were less significant than the ones reported in our
previous genome-wide scan study (Zhang et al., 2002),
probably due to the fact that more markers were analyzed
and an affected-only analysis was performed in this study.
The analysis of the 90 new families yielded a multipoint
NPL score of 3.15 (P¼0.00004) at the marker interval
D4S2997–D4S3033 and a multipoint HLOD score of 4.33
(a¼69%) at the marker interval D4S413–D4S2997 (Figure 1
and Table 1).
OSA using mean AAO as a covariate
OSA of all 151 families obtained a maximum OSA-LOD
score of 4.24 at the marker interval D4S413–D4S2997 in a
subset of 31 families whose mean AAO are up to 16.33 years
old. Based on permutation testing with 10,000 replicates, this
OSA-LOD score as well as the corresponding subset of 31
families is statistically significant with an empirical P-value
of 0.020. Subsequent multipoint parametric analysis of the
same 31 families obtained a highly significant homogeneity
LOD score of 4.18 at the marker interval D4S413–D4S2997
(Table 1), which is remarkably higher than the homogeneity
LOD score of 17.0 obtained from all 151 families. The
highly significant multipoint homogeneity LOD score was
supported by significant two-point homogeneity LOD scores
within the same genetic region: 3.12 at D4S2997, 3.05 at
D4S413 and 1.18 at D4S3008. A highly significant HLOD
score of 4.59 (a¼ 92%) was also obtained at the same marker
interval in the 31 families, whose a-value of 92% is
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Figure 1. Results of linkage analysis. The plots show the results of the
multipoint (a) nonparametric (NPL) and (b) parametric (HLOD) linkage
analysis of the whole 151 families (solid line); the 61 original families
(intertwist line) and the 90 new families (dashed line).
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substantially higher than the a-value of 45% of the HLOD
score from all 151 families (Table 1).
We also performed linkage analysis using the remaining
120 families whose mean AAO was above 16.33 years. The
maximum NPL and HLOD scores from the 120 families were
2.80 (P¼0.0009) and 1.84, respectively. These LOD scores
were much less significant than the ones from all 151 families
and the 31 families.
Defining the critical region of PSORS9
We estimated the 1-LOD-down supporting interval of
PSORS9, a commonly employed approach for defining the
critical region of linkage locus harboring the underlying
susceptibility gene. Based on the parametric HLOD score
result from all 151 families, the estimated supporting interval
is about 7 cM flanked by markers D4S3008 and D4S3033
(Table 1). Based on the homogeneity LOD score result
from the identified ordered subset of the 31 families, the
estimated supporting interval is about 5.5 cM flanked by
the same markers D4S3008 and D4S3033. We also estimated
the critical region of PSORS9 locus using GENEFINDER
analysis, a general multipoint linkage method for estimating
the chromosomal position of a putative susceptibility locus
based on the identical by descent sharing of affected relative
pairs (Glidden et al., 2003). The results from GENEFINDER
analysis were very similar to the above 1-LOD-down
supporting intervals (data not shown).
DISCUSSION
Compared to our previous genome-wide scan study, the
power of this follow-up study is greatly improved. First,
we have greatly increased our sample size to 151 families by
including an additional 90 new Chinese families with
psoriasis in the follow-up study. Second, the marker coverage
around the PSORS9 locus has also been considerably
improved by adding seven additional markers so that
almost all the meioses for linkage analysis were informative
in this study as indicated by the very high marker informa-
tion content of 93% within the region studied. The current
follow-up study was also improved by employing an affected-
only approach for parametric linkage analysis. Although
the affected-only analysis is generally considered to be
conservative in identifying linkage, its linkage evidence is
more convincing owing to its origin of evidence primarily
from affected familial members and its decreased depen-
dence on the maximization of the linkage evidence
overpenetrance rate.
This follow-up study provided confirmative evidence for
the linkage to the PSORS9 locus. By analyzing 13 markers in
151 families, we obtained highly significant parametric and
nonparametric LOD scores at the PSORS9 locus. Further-
more, our analysis of the independent sample of the 90 new
families also obtained highly significant linkage evidence.
Both the LOD scores from all 151 families and from the 90
independent families exceeded the genome-wide criteria for
significant linkage evidence. Therefore, our follow-up ana-
lysis of the 151 psoriatic families provided confirmative
evidence for the PSORS9 locus, and more importantly, the
highly significant linkage evidence from the analysis of the
independent sample of the 90 new families constitutes a
validation of our original linkage finding at the PSORS9
locus. Our confirmation is likely owing to the fact that the
PSORS9 locus plays a major role in Chinese families of
psoriasis and that both the original and new families were
Table 1. Summary of the multipoint LOD scores from the initial genome-wide and follow-up linkage analyses
Combined family
analysis (n=151) New families (n=90) Families with mean AAOo17 years (n=31)
Chromosomal
location Marker
Distance
(cM)1 NPL P-value HLOD a (%) NPL P-value HLOD a (%) NPL P-value HLOD
Homogeneity
LOD a (%)
4q28.2 D4S1575 132.05 1.24 0.08 0.78 20.3 0.86 0.13 0.93 34.9 1.08 0.11 1.18 0.31 54.1
4q28.3 D4S2972 140.64 1.77 0.02 1.05 19.3 1.50 0.029 1.51 35.7 1.29 0.068 1.19 3.68 42.6
4q31.1 D4S2939 142.24 1.81 0.02 1.00 18.2 1.61 0.021 1.62 35.5 1.41 0.052 1.35 5.18 44.9
4q31.1 D4S420 142.77 1.81 0.02 0.97 17.9 1.63 0.020 1.65 35.6 1.51 0.041 1.46 5.98 46.5
4q31.1 D4S424 144.56 2.65 0.001 1.97 27.5 2.52 0.00079 3.03 52.0 2.32 0.0038 2.31 2.89 61.9
4q31.1 D4S2981 145.98 2.99 0.0004 2.40 30.1 2.70 0.00035 3.51 58.5 2.47 0.0023 2.37 2.78 62.5
4q31.2 D4S3008 152.98 3.29 0.0001 3.13 38.1 2.82 0.00020 4.12 67.2 2.60 0.0014 2.43 0.42 67.2
4q31.3 D4S413 157.99 3.83 0.000008 4.41 46.4 2.94 0.00011 4.33 68.6 3.13 0.00016 4.20 3.87 91.4
4q31.3 D4S2997 158.65 3.91 0.000005 4.50 46.2 2.97 0.000096 4.30 68.0 3.23 0.00011 4.38 4.03 91.7
4q31.3 D4S3033 161.04 3.95 0.000004 4.06 42.5 3.12 0.000045 4.10 65.5 3.21 0.00012 4.15 3.63 90.8
4q32.1 D4S3046 162.47 3.88 0.000007 3.48 38.8 3.06 0.000061 3.35 58.7 3.02 0.00026 3.06 2.09 82.7
4q32.2 D4S620 167.55 3.18 0.0002 2.80 37.1 2.69 0.00037 2.72 55.2 2.65 0.0012 2.53 0.92 77.1
4q32.3 D4S2979 169.42 2.91 0.0003 2.34 32.6 2.64 0.00046 2.30 49.3 2.56 0.0016 1.81 1.09 63.5
AAO, age at onset; LOD, logarithms of odds.
1According to the genetic map at the Marshfield (Broman et al., 1998).
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recruited from the same clinics using the same diagnosis
criteria so that sample heterogeneity between the original
genome-wide and the follow-up validation studies has been
kept minimal.
We further investigated the possibility of AAO to be a
surrogate marker of genetic heterogeneity of psoriasis using
the OSA analysis. OSA analysis is a recently developed
statistical method to identify a homogeneous subset of
families that contributes to overall linkage at a given
chromosomal location and thus to potentially help in the
fine mapping and localization of a susceptibility gene within
a chromosomal area (Hauser et al., 2001, 2004; Shao et al.,
2003). One major advantage of OSA analysis is that it
does not require defining a priori cutoff value to divide the
sample into phenotypic subsets as performed in conventional
stratified linkage analysis. Unless a priori evidence for
defining a suitable cutoff is clear, choosing a particular cutoff
value of a disease-associated trait for stratifying families is
quite arbitrary, which makes it difficult to evaluate the
statistical significance of linkage results derived from such
arbitrarily defined subsets of families. Furthermore, the
permutation procedure of the OSA analysis allows a direct
evaluation of the significance of the linkage evidence from
subgroup analysis and thus the defined subset of families by
calculating empirical P-values.
Our OSA analysis provided some interesting findings and
important implications for future study of PSORS9. First, the
OSA analysis identified a remarkable homogeneous subset of
families for linkage to PSORS9, as suggested by the high
homogeneity LOD score associated with the family subset.
The identified subset includes 31 families whose mean AAOs
are up to 16.33 years old, which is interestingly very similar
to the AAO value commonly used for defining pediatric- or
early-onset psoriasis. Associated with AAO at adolescence,
the pediatric form of psoriasis had long been recognized and
shown to have a higher female/male ratio, frequency of
positive family history, and frequency of carriage of the
HLA-associated psoriasis risk than that of adult patients
(Melski and Stern, 1981; Henseler and Christophers, 1985;
Raychaudhuri and Gross, 2000). Psoriasis patients had also
been characterized into early- and late-onset cases using a
different AAO cutoff value of 40 years old, and the early-
onset patients were shown to be associated with a higher
frequency of positive family history and Cw6 carriers, higher
relative risk for first-degree relatives and more extensive skin
involvement (Elder et al., 1994; Ferrandiz et al., 2002; Stuart
et al., 2002). Although they used different AAO values for
defining early- and late-onset diseases, these studies did
suggest that early- and late-onset psoriases are probably two
genetically distinguishable groups of patients. The results
from our OSA analysis provided supporting linkage evidence
for such a suggestion and further indicated that AAO at
adolescence is a good value to characterize early- and late-
onset diseases, at least for defining more homogenous
samples for genetic analysis of the PSORS9 locus.
Second, our result of the OSA analysis is surprisingly
contradictive to what was found by Karason et al. (2005) in
the Icelandic population. Karason et al. (2005) found that
only the Icelandic families of late-onset psoriasis provided
supporting evidence for linkage to PSORS9, whereas our
result of OSA analysis clearly suggested that evidence for
linkage to PSORS9 is concentrated in the Chinese families of
early-onset psoriasis. In the Karason et al. (2005) study, a
traditional method for stratified linkage analysis was em-
ployed by first choosing an a priori AAO cutoff value of 17 to
divide the whole family sample into early- and late-onset
families and then performing linkage analysis in each subset
of families, which is quite different from the OSA analysis
performed in this study as discussed above. Although the
possibility cannot be totally ruled out, we argue that such a
striking difference in linkage result between these two studies
is less likely due to the methodological difference in
performing stratified linkage analysis between two studies.
We suggest that the difference may represent evidence for
genetic heterogeneity between ethnic populations in terms of
linkage to PSORS9. Such a suggestion is consistent with the
previous linkage findings in European populations that
reported very weak, if any, supporting evidence for PSORS9,
while the supporting evidence only emerged after the results
of these five studies were pooled together in a meta-genome-
scan analysis. Although the supporting linkage result of the
meta-genome-scan analysis did indicate that the same
susceptibility gene lying within PSORS9 likely plays a role
in both European and Chinese families of psoriasis (Bowcock,
2004; Sagoo et al., 2004), it also suggested that the gene is
expected to play only a very minor role in European
populations so that its impact on disease susceptibility can
only be detected using an extremely large sample such as
through meta analysis. In contrast, the gene is likely to play a
much stronger role in the Chinese population as indicated by
our previous genome-wide scan and current follow-up
analysis. Furthermore, our results strongly suggest that future
study of PSORS9 should focus on early-onset patients of
psoriasis, at least in the Chinese population.
We have refined the likely location of the underlying
susceptibility gene to a small region at 4q31.2–32.1. The
estimated location of the underlying susceptibility gene
within the PSORS9 locus from using different sample sets
and different methods is very consistent and indicates a much
smaller critical region at 4q31.2–32.1 than previously
suggested (Bowcock, 2004). There are 65 genes annotated
within the defined critical region of the PSORS9 locus,
several of which are plausible candidate genes for psoriasis
such as IL-15 and MGST2. IL-15 is a cytokine that triggers
inflammatory cell recruitment, angiogenesis, and production
of other inflammatory cytokines (Villadsen et al., 2003) and
has long been suggested as a strong candidate gene. MGST2
encodes a protein that catalyzes the conjugation of leuko-
triene A4 and reduced glutathione to produce leukotriene
C4, a competent immunomodulator (Jakobsson et al., 1996).
Two recent molecular genetic studies provided supporting
evidence for MGST2 to be involved in the pathogenesis of
psoriasis (Tzschach et al., 2006; Yan et al., 2006), but
our recent genetic association analysis of MGST2 in the
Chinese population did not provide supporting evidence for
its role in the susceptibility to psoriasis (unpublished data).
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Up to today, no susceptible genes have been identified within
the PSORS9 locus.
In conclusion, our follow-up analysis of the PSORS9
locus has confirmed our original linkage finding at the
PSORS9 locus and refined the linkage to a small region at
4q31.2–32.1, providing much improved mapping information
for future identification of the underlying susceptibility gene.
Furthermore, the results of the AAO-based OSA analysis
further demonstrated that the evidence for linkage is
concentrated in the families of early-onset psoriasis and thus
suggest that further genetic analysis of the PRORS9 locus
should focus on early-onset patients, at least in the Chinese
population. Together with other linkage findings at the
PSORS9, our results further suggested that Chinese and
European populations are likely different in terms of the
involvement of the disease gene of the PSORS9 locus in
susceptibility to psoriasis, which may partially explain the
suggested influence of ethnic factors on prevalence of
psoriasis (Christophers, 2001).
MATERIALS AND METHODS
Subjects
A total of 151 Chinese families with psoriasis, including 61 families
used in our previous genome-wide linkage study and 90 new
families, were analyzed in this follow-up study. All the families were
recruited from the Dermatology Department of the Anhui Medical
University using an ascertainment procedure described previously
(Zhang et al., 2002) and were summarized in Table 2. Briefly, the
present family sample includes 759 individuals, 404 of which
are affected (227 males and 177 females) and 354 of which are
unaffected (151 males and 203 females). All the families have at least
two affected siblings with an average of 2.7 affected siblings per
family. All the participating individuals provided informed written
consent. The study was approved by the Ethics Committee of the
Anhui Medical University and was conducted according to the
Declaration of Helsinki Principles.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes by
standard procedures (Miller et al., 1988). The primer sequences,
expected alleles, and allele frequencies of 13 microsatellite markers
studied here were obtained from the UniSTS Database (http://
www.ncbi.nlm.nih.gov/genome/sts/). All the markers were geno-
typed using a procedure described previously (Chen et al., 2005).
Briefly, PCR amplifications of microsatellite markers were performed
in uniplex condition, and PCR products were pooled together and
analyzed on an automated ABI PRISM 3730 DNA sequencer
(Applied Biosystems, Foster City, CA). GeneMapper 3.0 software
(Applied Biosystems) was used for determining genotypes that were
further reviewed by two persons independently. All the genotypes
were examined for Mendelian inconsistencies by PedCheck
(O’Connell and Weeks, 1998) and double-recombinations by
Merlin (Abecasis et al., 2002). Problematic genotypes were re-typed
for confirmation. When a problematic genotype could not be
resolved by re-typing analysis the genotype as well as the related
genotypes of family members was removed from further analysis.
About 1% of the genotypes were set to be missing owing to unsolved
problematic genotypes.
Statistical analysis
We performed both parametric and nonparametric linkage analyses
using GENEHUNTER 2.0 (Kruglyak et al., 1996). For parametric
linkage analysis, both homogeneity and heterogeneity LOD scores
were calculated by using the same genetic model as the one used
in our previous genome-wide linkage analysis: dominant inheri-
tance of a disease allele with a population frequency of 0.00062
(Zhang et al., 2002). Furthermore, in order to reduce the
adverse impact of nonpenetrant disease alleles on linkage
results, parametric analysis was performed using an ‘‘affected-only’’
approach in which all normal individuals were treated as
‘‘unknown’’ instead of ‘‘unaffected’’. For nonparametric linkage
analysis an NPL score was calculated using Sall statistics that is more
powerful than Spair statistics by capturing allele sharing informa-
tion between all affected individuals within a pedigree (Kruglyak
et al., 1996).
To evaluate whether AAO is a surrogate marker of genetic
heterogeneity for psoriasis, we performed an OSA using the mean
AAO of each family as the covariate and the procedure proposed by
Hauser et al. (2004). Briefly, the OSA we performed goes as follows.
The 151 families were first ranked according to their mean AAOs
from youngest to oldest. Starting with the family with the smallest
mean AAO, we formed subsets of families by adding families one at
a time in the order induced by the ranks of the families. Thus, a total
of 151 subsets were formed, the first one consisting of only the family
with the smallest mean AAO, the second one consisting of the two
families with the smallest and the second smallest mean AAO, and
so on. For each subset of families, the family-specific location LOD
vectors were summed and maximized over the putative positions of
the disease gene. We refer to the maximum of the location LOD
obtained for each subset as the ‘‘OSA-LOD score’’. The subset
with the highest OSA-LOD score was then identified along with
its member families. The OSA-LOD score of the largest subset,
Table 2. Details of psoriasis families used for
genotyping
New
families
Original
families1
All
families
Two affected members 66 17 83
Three affected members 19 33 52
Four affected members 3 6 9
Five to 10 affected members 2 5 7
Total independent families 90 61 151
Total affected family members 215 189 404
Total affected male 120 107 227
Total affected female 95 82 177
Total family members 404 355 759
One-generation families 17 1 18
Two-generation families 65 51 116
Three-generation families 12 9 21
1Families used in our previous genome-wide linkage analysis (Zhang
et al., 2002).
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that is, the one consisting of all 151 families, was taken as the
baseline OSA-LOD score. The difference between the highest
OSA-LOD score and the baseline OSA-LOD score was taken as
the test statistics. The significance of the impact of AAO was then
tested by using the test statistics and a permutation procedure (1,000
permutations). A significant impact of AAO implies that the
identified subset has a significantly larger OSA-LOD score than the
baseline OSA-LOD score. Finally, multipoint parametric and
nonparametric analyses were performed using the identified subset
of families.
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